Cargando…
Current peptide vaccine and immunotherapy approaches against Alzheimer's disease
Peptide vaccines and immunotherapies against aggregating proteins involved in the pathogenesis and progression of Alzheimer's disease (AD)—the β‐amyloid peptide (Aβ) and tau—are promising therapeutic avenues against AD. Two decades of effort has led to the controversial United States Food and D...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9916509/ https://www.ncbi.nlm.nih.gov/pubmed/36778914 http://dx.doi.org/10.1002/pep2.24289 |